Steven George Hughes insider trades: Atrium Therapeutics (RNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
Open-market buys and sales
10 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | RNA | ↓ Sell10b5-1 | 4,895 | $72.45 | $355K | Direct | Jan 23, 2026 (2d) |
| Oct 22, 2025 | RNA | ↓ Sell | 2,209 | $47.54 | $105K | Direct | Oct 24, 2025 (2d) |
| Sep 22, 2025 | RNA | ↓ Sell | 2,208 | $40.58 | $90K | Direct | Sep 23, 2025 (1d) |
| Sep 15, 2025 | RNA | ↓ Sell | 1,542 | $45.41 | $70K | Direct | Sep 17, 2025 (2d) |
| Aug 22, 2025 | RNA | ↓ Sell | 2,208 | $46.40 | $102K | Direct | Aug 22, 2025 (0d) |
| Aug 13, 2025 | RNA | ↓ Sell | 1,542 | $46.66 | $72K | Direct | Aug 15, 2025 (2d) |
| Aug 6, 2025 | RNA | ↓ Sell | 81,434 | $42.74 | $3.5M | Direct | Aug 8, 2025 (2d) |
| Mar 20, 2025 | RNA | ↓ Sell10b5-1 | 9,578 | $31.06 | $297K | Direct | Mar 21, 2025 (1d) |
| Jan 21, 2025 | RNA | ↓ Sell10b5-1 | 3,947 | $28.59 | $113K | Direct | Jan 23, 2025 (2d) |
| Aug 16, 2019 | ONVO | ↓ Sell | 22,230 | $0.29 | $6K | Direct | Aug 19, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RNA insiders
Open-market trades in the last 12 months
About Steven George Hughes's insider trades
Steven George Hughes is Chief Medical Officer at Atrium Therapeutics (RNA). Since Aug 16, 2019, Steven has reported no open-market purchases and 10 sales worth $4.7M on SEC Form 4. In the last 12 months: 1 sale ($355K).
3 sales (16% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (6 filings), grants and awards (5 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.